Research Article

Metabolic Syndrome and Its Components Predict the Risk of Type 2 Diabetes Mellitus in the Mainland Chinese: A 3-Year Cohort Study

Table 1

Baseline characteristics of participants included in the follow-up study according to the presence of incident T2DM.

CharacteristicIncident T2DM at 3-year follow-up
No ()Yes () value

Age (years)43.21 ± 13.2352.78 ± 12.72<0.001
Gender, no. (%)<0.001
 Male5087 (58.90%)801 (72.88%)
 Female3549 (41.10%)298 (27.12%)
BMI (kg/m2)23.45 ± 3.1625.33 ± 3.11<0.001
Plasma glucose
 FBG (mmol/L)4.92 ± 0.505.29 ± 0.68<0.001
 PG2h (mmol/L)6.51 ± 1.257.68 ± 1.37<0.001
Blood pressure
 Systolic (mm Hg)116.33 ± 15.70125.33 ± 16.97<0.001
 Diastolic (mm Hg)77.52 ± 10.1381.70 ± 10.56<0.001
 Pulse pressure (mm Hg)38.81 ± 10.7343.63 ± 12.66<0.001
Lipid profile (mmol/L)
 Total cholesterol4.77 ± 0.825.23 ± 0.92<0.001
 HDL cholesterol1.54 ± 0.361.46 ± 0.36<0.001
 LDL cholesterol2.47 ± 0.652.74 ± 0.71<0.001
 Triglycerides1.22 (0.86–1.78)1.91 (1.35–2.73)<0.001
Metabolic syndrome, no. (%)429 (5.6)457 (29.3)<0.001
 Overweight2231 (29.95%)483 (50.47%)<0.001
 IGR1551 (17.96%)625 (56.87%)<0.001
  FBG ≥ 6.1 mmol/L212 (2.48%)163 (14.87%)<0.001
  PG2h ≥ 7.8 mmol/L1452 (16.81%)598 (54.41%)<0.001
 Hypertension1876 (23.45%)490 (47.90%)<0.001
 Dyslipidemia2556 (29.98%)591 (54.07%)<0.001
  TG ≥ 1.7 mmol/L2361 (27.70%)655 (59.93%)<0.001
  Low HDLc297 (3.76%)63 (6.46%)<0.001

Data are shown as means ± SD, median (interquartile range), or no (%). T2DM: type 2 diabetes mellitus; IGR: impaired glucose regulation; FBG: fasting blood glucose; PG2h: 2-hour postprandial plasma glucose; TG: triglycerides; HDLc: high-density lipoprotein cholesterol. Overweight: defined as BMI greater than 25.0 kg/m2; hypertension: defined as systolic/diastolic blood pressure ≥ 140/90 mmHg or taking antihypertensive agents; low HDL cholesterol: defined as fasting HDL-C < 0.9 or <1.0 mmol/L in males and females, respectively. The number of participants for each category varies slightly due to occasional missing values.